Mixed Acid Salt Polymer-Drug Conjugates for Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing water-soluble polymer-drug conjugates face challenges such as poor aqueous solubility, toxicity, low bioavailability, and instability, particularly in achieving pure and reproducible polymerization products suitable for pharmaceutical use, with conventional approaches resulting in impure compositions and low yields.
Innovation Solution
The development of mixed acid salt forms of water-soluble polymer-active agent conjugates, where the active agent has amine or basic nitrogen-containing groups that are either protonated or unprotonated, forming salts with strong inorganic or organic acids like trifluoroacetic acid, and the use of alkoxylation methods to produce high-purity alkoxylated polymeric materials for conjugate synthesis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional polymerization methods are used to prepare water-soluble polymer-drug conjugates, then the synthesis process is simple, but the product purity is low and yield is poor
Solution Approach 1:
The patent changes the chemical parameters of the polymerization process by using specific activating groups (such as activated esters, activated halides, or isocyanates) on the polymer and matching them with corresponding functional groups on the drug molecule. This parameter change enables controlled conjugation while maintaining high purity and yield, resolving the contradiction between manufacturing precision and process complexity.
Solution Approach 2:
The patent introduces an intermediary coupling mechanism where the polymer and drug are linked through a reactive intermediate complex formed by the interaction of activating groups on the polymer with complementary groups on the drug. This intermediary approach allows for high-purity conjugate formation without requiring complex multi-step procedures, thus improving manufacturing precision without significantly increasing device complexity.
2Reliability
If polymer-drug conjugates are prepared to improve water solubility and stability, then bioavailability is improved, but formulation consistency and reproducibility become difficult to achieve
Solution Approach 1:
The patent segments the conjugate formation process into distinct modular steps: (1) preparation of polymer with specific activating groups, (2) preparation of drug with complementary functional groups, and (3) controlled coupling under defined conditions. This segmentation allows for standardized, reproducible formulation while maintaining high stability, resolving the contradiction between reliability and manufacturing precision.
Solution Approach 2:
The patent establishes specific parameter ranges for the conjugation process (such as temperature, pH, reaction time, and stoichiometry) that can be consistently reproduced across batches. By optimizing these parameters, the patent achieves both high conjugate stability and formulation consistency, eliminating the trade-off between reliability and manufacturing precision.
3Reliability
If mixed acid salt forms are used to enhance conjugate stability, then bioavailability is improved, but the complexity of salt form control increases
Solution Approach 1:
The patent changes the chemical state parameters of the conjugate by forming mixed acid salts with specific ratios of inorganic and organic acids. This parameter change enhances stability and bioavailability while the method provides clear control guidelines for salt formation, reducing the actual complexity of implementation despite the increased chemical complexity.
Solution Approach 2:
The patent uses established salt formation methodologies that replicate proven approaches from pharmaceutical chemistry, adapting them to polymer-drug conjugates. By copying and adapting successful salt formation protocols, the patent achieves enhanced stability without proportionally increasing control complexity, as the underlying principles are well-understood and can be systematically applied.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances the stability and bioavailability of the conjugates, reducing impurities and improving the consistency of polymer-drug formulations, making them more suitable for pharmaceutical applications by achieving higher purity and stability of the polymer backbone.
Implementation Method 1
a method comprising the step of alkoxylating in a suitable solvent a previously isolated alkoxylatable oligomer to form an alkoxylated polymeric product
Implementation Method 2
the active agent in the conjugate has at least one amine or other basic nitrogen-containing group, and further wherein the amine or other basic nitrogen-containing group is either protonated or unprotonated
Data Source
AI summary
Among other aspects, provided herein is a mixed-acid salt of a water-soluble polymer-drug conjugate, along with related methods of making and using the same. The mixed-salt acid salt is stably formed, and appears to be more resistant to hydrolytic degradation than the corresponding predominantly pure acid salt or free base forms of the polymer-drug conjugate. The mixed acid salt is reproducibly prepared and recovered, and provides surprising advantages over non-mixed acid salt forms of the water-soluble polymer drug conjugate.